SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-13-000993
Filing Date
2013-03-14
Accepted
2013-03-14 08:01:16
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031413.htm 10-K 1419971
2 EXHIBIT 23.1 exh_231.htm EX-23.1 9036
3 EXHIBIT 31.1 exh_311.htm EX-31.1 12007
4 EXHIBIT 31.2 exh_312.htm EX-31.2 12644
5 EXHIBIT 32.1 exh_321.htm EX-32.1 9601
  Complete submission text file 0001171843-13-000993.txt   4723057

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT caps-20121231.xml EX-101.INS 422861
7 XBRL TAXONOMY EXTENSION SCHEMA caps-20121231.xsd EX-101.SCH 40430
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20121231_cal.xml EX-101.CAL 33420
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20121231_def.xml EX-101.DEF 175983
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20121231_lab.xml EX-101.LAB 322501
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20121231_pre.xml EX-101.PRE 229576
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33560 | Film No.: 13689133
SIC: 2834 Pharmaceutical Preparations